{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:04:18Z","timestamp":1761948258702},"reference-count":34,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpem-2016-0340_s_999_w2aab2b8c29b1b7b1aab1c14b1Aa\">\n                  <jats:title>Background:<\/jats:title>\n                  <jats:p>During puberty there is a physiologic increase in adrenal and ovarian androgens. It has been suggested that the somatotrophic axis may be related to the development of hyperandrogenism and anovulation in non-obese adult women with polycystic ovarian syndrome (PCOS). The objective of the study was to investigate whether ovarian androgen secretion in young postmenarchal girls is related to the function of their somatotropic axis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2016-0340_s_998_w2aab2b8c29b1b7b1aab1c14b2Aa\">\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>This was a cross-sectional study of adolescent girls. We studied non-obese adolescent girls with hyperandrogenism (HA; n = 21) matched with control girls (C; n = 25) for chronological age, age at menarche and body mass index. We obtained a fasting blood sample for measurement of serum glucose, insulin, 17-hydroxyprogesterone (17OH-Prog), dehydroepiandrosterone-sulfate (DHEA-S), androstenedione, sex hormone-binding globulin (SHBG), total testosterone, IGF-I, IGF-II, IGFBP-1, IGFBP-3, ghrelin, leptin, AMH (antiM\u00fcllerian hormone), luteinizing hormone (LH) and follicle stimulating hormone (FSH) during the follicular phase of the menstrual period. We performed an oral glucose tolerance test to determine blood glucose, insulin and ghrelin levels and urine samples to measure urinary GH (growth hormone) levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2016-0340_s_997_w2aab2b8c29b1b7b1aab1c14b3Aa\">\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>As expected, the hyperandrogenic girls had significantly higher Ferriman scores, basal total testosterone, free androgen index (FAI), androstenedione, AMH, and basal LH levels compared with the girls in controls. Serum IGF-I, IGF-II, IGFBP-3 and urinary GH did not differ between HA and C. There was a correlation between urinary GH and FAI in all girls (r 0.29, p &lt; 0.05). In addition, in HA girls FAI correlated with insulin, homeostasis model assessment (HOMA) and ghrelin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2016-0340_s_996_w2aab2b8c29b1b7b1aab1c14b4Aa\">\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>We observed a correlation between urinary GH and FAI in the hyperandrogenic and control girls, suggesting that the function of the somatotrophic axis may influence the secretion of androgens in adolescent girls.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2016-0340","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T10:01:30Z","timestamp":1493546490000},"page":"561-568","source":"Crossref","is-referenced-by-count":8,"title":["Hyperandrogenism in adolescent girls: relationship with the somatotrophic axis"],"prefix":"10.1515","volume":"30","author":[{"given":"Mar\u00eda Isabel","family":"Hernandez","sequence":"first","affiliation":[{"name":"School of Medicine, University of Chile, Institute of Maternal and Child Research, Santiago de Chile, Chile, P.O. Box 226\u20133, Santiago, Chile , Phone: +56 2 4248280, Fax: +56 2 4247240"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, Chile"},{"name":"Hospital Cl\u00ednico San Borja Arriar\u00e1n, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximena","family":"Gaete","sequence":"additional","affiliation":[{"name":"Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, Chile"},{"name":"Hospital Cl\u00ednico San Borja Arriar\u00e1n, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Villarroel","sequence":"additional","affiliation":[{"name":"Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Cavada","sequence":"additional","affiliation":[{"name":"Department of Public Health, University of Chile and University of los Andes, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Avila","sequence":"additional","affiliation":[{"name":"Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, Chile"},{"name":"Hospital Cl\u00ednico San Borja Arriar\u00e1n, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"I\u00f1iguez","sequence":"additional","affiliation":[{"name":"Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Cassorla","sequence":"additional","affiliation":[{"name":"Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,4,29]]},"reference":[{"key":"2022053105150189565_j_jpem-2016-0340_ref_001_w2aab2b8c29b1b7b1ab2b2b1Aa","doi-asserted-by":"crossref","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745\u20139.","DOI":"10.1210\/jc.2003-032046"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_002_w2aab2b8c29b1b7b1ab2b2b2Aa","unstructured":"Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, editors. Polycystic ovary syndrome. Boston, MA: Blackwell Scientific Publications, 1992:377\u201384."},{"key":"2022053105150189565_j_jpem-2016-0340_ref_003_w2aab2b8c29b1b7b1ab2b2b3Aa","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_004_w2aab2b8c29b1b7b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41\u20137.","DOI":"10.1093\/humrep\/deh098"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_005_w2aab2b8c29b1b7b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"Meas T, Chevenne D, Thibaud E, L\u00e9ger J, Cabrol S, et al. Endocrine consequences of premature pubarche in post-pubertal Caucasian girls. Clin Endocrinol (Oxf) 2002;57:101\u20136.","DOI":"10.1046\/j.1365-2265.2002.01579.x"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_006_w2aab2b8c29b1b7b1ab2b2b6Aa","doi-asserted-by":"crossref","unstructured":"Witchel SF, Oberfield S, Rosenfield RL, Codner E, Bonny A, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr 2015;83:376\u201389.","DOI":"10.1159\/000375530"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_007_w2aab2b8c29b1b7b1ab2b2b7Aa","doi-asserted-by":"crossref","unstructured":"Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, et al. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 2003;18:598\u2013603.","DOI":"10.1093\/humrep\/deg115"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_008_w2aab2b8c29b1b7b1ab2b2b8Aa","doi-asserted-by":"crossref","unstructured":"Williams RM, Ong KK, Dunger DB. Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol 2013;373:61\u20137.","DOI":"10.1016\/j.mce.2013.01.005"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_009_w2aab2b8c29b1b7b1ab2b2b9Aa","doi-asserted-by":"crossref","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, et al. American association of clinical endocrinologists, american college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome \u2013 part 1. Endocr Pract 2015;21:1291\u2013300.","DOI":"10.4158\/EP15748.DSC"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_010_w2aab2b8c29b1b7b1ab2b2c10Aa","doi-asserted-by":"crossref","unstructured":"Davoren JB, Kasson BG, Li CH, Hsueh AJ. Specific insulin-like growth factor I- and II-binding sites on rat granulosa cells: relation to IGF action. Endocrinology 1986;119:2155\u201362.","DOI":"10.1210\/endo-119-5-2155"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_011_w2aab2b8c29b1b7b1ab2b2c11Aa","doi-asserted-by":"crossref","unstructured":"Davoren JB, Hsueh AJ, Li CH. Somatomedin C augments FSH induced differentiation of cultured rat granulose cells. Am J Physiol 1985;249:E26\u201333.","DOI":"10.1152\/ajpendo.1985.249.1.E26"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_012_w2aab2b8c29b1b7b1ab2b2c12Aa","doi-asserted-by":"crossref","unstructured":"Morales AJ, Laughlin GA, B\u00fctzow T, Maheshwari H, Baumann G, et al. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996;81:2854\u201364.","DOI":"10.1210\/jcem.81.8.8768842"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_013_w2aab2b8c29b1b7b1ab2b2c13Aa","doi-asserted-by":"crossref","unstructured":"Garcia-Rudaz MC, Ropelato MG, Escobar ME, Veldhuis JD, Barontini M. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome. Eur J Endocrinol 2002;147:207\u201316.","DOI":"10.1530\/eje.0.1470207"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_014_w2aab2b8c29b1b7b1ab2b2c14Aa","doi-asserted-by":"crossref","unstructured":"Fusco A, Bianchi A, Mancini A, Milardi D, Giampietro A, et al. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome. J Endocrinol Invest 2007;30:948\u201356.","DOI":"10.1007\/BF03349243"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_015_w2aab2b8c29b1b7b1ab2b2c15Aa","doi-asserted-by":"crossref","unstructured":"Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291\u2013303.","DOI":"10.1136\/adc.44.235.291"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_016_w2aab2b8c29b1b7b1ab2b2c16Aa","doi-asserted-by":"crossref","unstructured":"Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440\u201347.","DOI":"10.1210\/jcem-21-11-1440"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_017_w2aab2b8c29b1b7b1ab2b2c17Aa","doi-asserted-by":"crossref","unstructured":"Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666\u201372.","DOI":"10.1210\/jcem.84.10.6079"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_018_w2aab2b8c29b1b7b1ab2b2c18Aa","doi-asserted-by":"crossref","unstructured":"Soto N, I\u00f1iguez G, L\u00f3pez P, Larenas G, Mujica V, et al. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Hum Reprod 2009;24:2838\u201344.","DOI":"10.1093\/humrep\/dep276"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_019_w2aab2b8c29b1b7b1ab2b2c19Aa","doi-asserted-by":"crossref","unstructured":"I\u00f1iguez G, Villavicencio A, Gabler F, Palomino A, Vega M. Effect of nitric oxide on the expression of insulin-like growth factors and the insulin-like growth factor binding proteins throughout the lifespan of the human corpus luteum. Reproduction 2001;122:865\u201373.","DOI":"10.1530\/rep.0.1220865"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_020_w2aab2b8c29b1b7b1ab2b2c20Aa","doi-asserted-by":"crossref","unstructured":"Swanson M, Sauerbrei EE, Cooperberg PL. Medical implications of ultrasonically detected polycystic ovaries. J Clin Ultrasound 1981;9:219\u201322.","DOI":"10.1002\/jcu.1870090504"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_021_w2aab2b8c29b1b7b1ab2b2c21Aa","doi-asserted-by":"crossref","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013;98:4565\u201392.","DOI":"10.1210\/jc.2013-2350"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_022_w2aab2b8c29b1b7b1ab2b2c22Aa","doi-asserted-by":"crossref","unstructured":"van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, et al. Insulin, androgen, and gonadotropin concentrations, body mass index, and waist to hip ratio in the first years after menarche in girls with regular menstrual cycles, irregular menstrual cycles, or oligomenorrhea. J Clin Endocrinol Metab 2000;85:1394\u20131400.","DOI":"10.1210\/jc.85.4.1394"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_023_w2aab2b8c29b1b7b1ab2b2c23Aa","doi-asserted-by":"crossref","unstructured":"Rosenfield RL. Clinical review: adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab 2013;98:3572\u201383.","DOI":"10.1210\/jc.2013-1770"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_024_w2aab2b8c29b1b7b1ab2b2c24Aa","doi-asserted-by":"crossref","unstructured":"Apter D, Vihko R. Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab 1990;71:970\u201374.","DOI":"10.1210\/jcem-71-4-970"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_025_w2aab2b8c29b1b7b1ab2b2c25Aa","doi-asserted-by":"crossref","unstructured":"Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol 2010;203:e201\u20135.","DOI":"10.1016\/j.ajog.2010.03.008"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_026_w2aab2b8c29b1b7b1ab2b2c26Aa","doi-asserted-by":"crossref","unstructured":"Kazer RR, Unterman TG, Glick RP. An abnormality of the growth hormone\/insulin-like growth factor- I axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1990;71:958\u201362.","DOI":"10.1210\/jcem-71-4-958"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_027_w2aab2b8c29b1b7b1ab2b2c27Aa","doi-asserted-by":"crossref","unstructured":"Prelevi\u0107 GM, Wurzburger MI, Balint-Peri\u0107 L, Ginsburg J. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm Res 1992;37:125\u201331.","DOI":"10.1159\/000182296"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_028_w2aab2b8c29b1b7b1ab2b2c28Aa","doi-asserted-by":"crossref","unstructured":"de Boer JA, Lambalk CB, Hendriks HH, van Aken C, van der Veen EA, et al. Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome. Hum Reprod 2004;19:504\u20139.","DOI":"10.1093\/humrep\/deh122"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_029_w2aab2b8c29b1b7b1ab2b2c29Aa","doi-asserted-by":"crossref","unstructured":"Thierry van Dessel HJ, Chandrasekher Y, Yap OW, Lee PD, Hintz RL, et al. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGFbinding protein-1 and -3 during the normal menstrual cycle. J Clin Endocrinol Metab 1996;81:1224\u201331.","DOI":"10.1210\/jcem.81.3.8772603"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_030_w2aab2b8c29b1b7b1ab2b2c30Aa","doi-asserted-by":"crossref","unstructured":"Klinger B, Anin S, Silbergeld A, Eshet R, Laron Z. Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol (Oxf) 1998;48:81\u20137.","DOI":"10.1046\/j.1365-2265.1998.00356.x"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_031_w2aab2b8c29b1b7b1ab2b2c31Aa","unstructured":"Yen SS. Polycystic ovary syndrome (hyperandrogenic chronic anovulation). In: Yen SS, Jaffe RB, Barbieri RL, editors. Reproductive endocrinology: physiology, pathophysiology and clinical management. Philadelphia: Saunders Company Press, 1999;17:436\u201378."},{"key":"2022053105150189565_j_jpem-2016-0340_ref_032_w2aab2b8c29b1b7b1ab2b2c32Aa","doi-asserted-by":"crossref","unstructured":"Zhang G, Garmey JC, Veldhuis JD. Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17{alpha}-hydroxylase\/17, 20-lyase (CYP17) genes in porcine theca cells. Endocrinology 2000;141:2735\u201342.","DOI":"10.1210\/endo.141.8.7595"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_033_w2aab2b8c29b1b7b1ab2b2c33Aa","doi-asserted-by":"crossref","unstructured":"Kirchner H, Tong J, Tsch\u00f6p MH, Pfluger PT. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants. Am J Physiol Endocrinol Metab 2010;298:E909\u201319.","DOI":"10.1152\/ajpendo.00191.2009"},{"key":"2022053105150189565_j_jpem-2016-0340_ref_034_w2aab2b8c29b1b7b1ab2b2c34Aa","doi-asserted-by":"crossref","unstructured":"Barber TM, Casanueva FF, Karpe F, Lage M, Franks S, et al. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome. Eur J Endocrinol 2008;158:511\u20136.","DOI":"10.1530\/EJE-07-0683"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpem.2017.30.issue-5\/jpem-2016-0340\/jpem-2016-0340.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0340\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0340\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T05:15:49Z","timestamp":1653974149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0340\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,29]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,4,29]]},"published-print":{"date-parts":[[2017,5,1]]}},"alternative-id":["10.1515\/jpem-2016-0340"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2016-0340","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,29]]}}}